Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
No-LVT: Rivaroxaban vs Warfarin for Left Ventricular Thrombus
NCT03926780Phase 3Completed
- Sponsor
- Young Investigator Group of Cardiovascular Research
- Start
- Dec 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Left ventricular thrombosis (LVT), sponsored by Young Investigator Group of Cardiovascular Research. Started Dec 2018; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Left ventricular thrombosis (LVT)
Beyond the preview
Go deeper on NCT03926780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03926780.